Fonte: Investigational New Drugs. Unidade: FCF
Assuntos: MELANOMA, NEOPLASIAS CUTÂNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Luana Mota et al. Xanthan gum-based hydrogel containing nanocapsules for cutaneous diphenyl diselenide delivery in melanoma therapy. Investigational New Drugs, v. 38, p. 662-674, 2020Tradução . . Disponível em: https://doi.org/10.1007/s10637-019-00823-2. Acesso em: 31 ago. 2024.APA
Ferreira, L. M., Sari, M. H. M., Azambuja, J. H., Silveira, E. F. da, Cervi, V. F., Marchiori, M. C. L., et al. (2020). Xanthan gum-based hydrogel containing nanocapsules for cutaneous diphenyl diselenide delivery in melanoma therapy. Investigational New Drugs, 38, 662-674. doi:10.1007/s10637-019-00823-2NLM
Ferreira LM, Sari MHM, Azambuja JH, Silveira EF da, Cervi VF, Marchiori MCL, Maria-Engler SS, Wink MR, Azevedo JG, Nogueira CW, Braganhol E, Cruz L. Xanthan gum-based hydrogel containing nanocapsules for cutaneous diphenyl diselenide delivery in melanoma therapy [Internet]. Investigational New Drugs. 2020 ; 38 662-674.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1007/s10637-019-00823-2Vancouver
Ferreira LM, Sari MHM, Azambuja JH, Silveira EF da, Cervi VF, Marchiori MCL, Maria-Engler SS, Wink MR, Azevedo JG, Nogueira CW, Braganhol E, Cruz L. Xanthan gum-based hydrogel containing nanocapsules for cutaneous diphenyl diselenide delivery in melanoma therapy [Internet]. Investigational New Drugs. 2020 ; 38 662-674.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1007/s10637-019-00823-2